Z-1995-2021Class II
MaxPlusTM bi fuse extension set with 2 clear needleless connectors -
CareFusion 303, Inc / initiated 2021-06-09 / Terminated
CAREFUSION began a recall of MaxPlusTM bi fuse extension set with 2 clear needleless connectors - Product Usage: The needleless connector can be used for direct injection, intermittent... on . FDA classified it as Class II and gives the reason as "A portion of a validation lot was inadvertently released to the US Market. The product did not meet the validation testing criteria regarding leakage". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1995-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- CareFusion 303, Inc
- Product
- MaxPlusTM bi fuse extension set with 2 clear needleless connectors - Product Usage: The needleless connector can be used for direct injection, intermittent infusion, continuous infusion, or aspiration.
- Product code
- FPA Set, Administration, Intravascular
- Reason for recall
- A portion of a validation lot was inadvertently released to the US Market. The product did not meet the validation testing criteria regarding leakage.
- FDA root cause
- Under Investigation by firm
- Action
- On 06/09/2021, the firm sent an "URGENT MEDICAL DEVICE RECALL" Notification letter via email and FedEx to customers informing them that a validation lot was inadvertently released to the US market. This product did not meet the validation testing criteria regarding leakage. Potential health consequences associated with the use of the non-validated product is under-infusion. Customers are instructed to: 1. Immediately review their inventory for the specific Catalog (Ref) and lot numbers listed. Destroy all product subject to the recall following their institutions process for destruction. The Recalling Firm will replace discarded product. 2. Share this recall notification with all users within or outside their facility network to which you they have further distributed the affected products to ensure they are also aware of this recall. 3. Complete the attached Customer Response Form and return to the Recalling Firm's contact noted on the form (BD Post Market Quality Email: [email protected], Or Fax No.: 312-949-0236) whether or not they have any of the impacted material so that the Recalling Firm may acknowledge their receipt of this notification per FDA requirements and subsequently process their product replacement. For any questions or assistance contact: North American Regional Complaint Center 1-84BD-LIFE (1-844-823-5433) Say Recall when prompted MonFri 8:00am and 5:00pm CT
- Quantity in commerce
- 100 units
- Distribution
- U.S.: TN O.U.S.: None
- Product codes and lots
- Catalog Number:MP9246-C GTIN: 10885403237157 Lot Number: 20087194
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1995-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
